Skip to main content
Healthcare

STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test

STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test

Feed excerpt — reported by STAT News

Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.